Filgotinib is a selective JAK1 inhibitor with IC50 of 10 nM, 28 nM, 810 nM, and 116 nM for JAK1, JAK2, JAK3, and TYK2, respectively.

Market Analysis and Insights: Global and Japan Filgotinib Market
This report focuses on global and Japan Filgotinib market.
In 2020, the global Filgotinib market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. In Japan the Filgotinib market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Filgotinib Scope and Market Size
Filgotinib market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Filgotinib market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For Japan market, this report focuses on the Filgotinib market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in Japan.

Segment by Type
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%

Segment by Application
Research
Medical

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Cayman Chemical
BioVision
Adooq Bioscience
Taiclone
Clearsynth
Biorbyt
APExBIO Technology
Selleck Chemicals
AbMole
BOC Sciences
TargetMol
Toronto Research Chemicals
J&K Scientific